Benzyl Alcohol

Benzyl Alcohol

SCHEMBL1014536

Brc1ccccc1.OCc1ccccc1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.74
TDP1 Q9NUW8 3/20 0.58
ALDH1A1 P00352 3/20 0.58
LTA4H P09960 1/20 0.48
TRPA1 O75762 1/20 0.43
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
CALM1 P0DP23 1/20 0.41
MAOB P27338 1/20 0.41
MGLL Q99685 1/20 0.40
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
CNR2 P34972 1/20 0.39
THRB P10828 1/20 0.39
IDO1 P14902 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
AKR1B1 P15121 1/20 0.39
VHL P40337 1/20 0.38
ELOC Q15369 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzyl Alcohol SCHEMBL11361278 0.92 TSHR (0.70) TSHRTDP1ALDH1A1LTA4HTRPA1
Benzyl Alcohol SCHEMBL11680991 0.86 TSHR (1.00) TSHRTDP1ALDH1A1LTA4HTRPA1
Benzyl Alcohol SCHEMBL433990 0.86 TSHR (1.00) TSHRTDP1ALDH1A1LTA4HTRPA1
Benzyl Alcohol SCHEMBL11353823 0.86 TSHR (1.00) TSHRTDP1ALDH1A1LTA4HTRPA1
Benzyl Alcohol SCHEMBL9066990 0.86 TSHR (1.00) TSHRTDP1ALDH1A1LTA4HTRPA1
Benzyl Alcohol SCHEMBL1332097 0.86
Benzyl Alcohol SCHEMBL147 0.86
Benzyl Alcohol SCHEMBL11701213 0.83 TSHR (0.93) TSHRTDP1ALDH1A1LTA4HTRPA1
Benzyl Alcohol SCHEMBL6918395 0.83
Benzyl Alcohol SCHEMBL2864547 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102643178-A Preparation methods of lasofoxifene tartrate and intermediate thereof ZHEJIANG HUAHAI PHARM CO LTD 2012-08-22 CN disclosed
EP-2272858-A2 HCV inhibitors comprising beta amino acids and their uses Novartis AG (CH) 2011-01-12 EP disclosed
US-20080045530-A1 Organic Compounds and Their Uses BRANDL TRIXI 2008-02-21 US disclosed
EP-0596057-B1 QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS ZENECA LTD (GB) 1998-09-09 EP disclosed
WO-1993021183-A1 QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS ZENECA LIMITED (GB) 1993-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045530-A1 Organic Compounds and Their Uses OAT, OTC, AOX1 TSHR 3678/4885TDP1 936/4885ALDH1A1 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.